Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 15:12:27.
doi: 10.1186/s12981-015-0070-y. eCollection 2015.

HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users

Valentine Budambula  1 , Francis O Musumba  2 , Mark K Webale  3 , Titus M Kahiga  4 , Francisca Ongecha-Owuor  5 , James N Kiarie  6 , George A Sowayi  7 , Aabid A Ahmed  8 , Collins Ouma  9 , Tom Were  10
Affiliations

HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users

Valentine Budambula et al. AIDS Res Ther. .

Abstract

Background: Although injection drug use drives antiretroviral drug resistance, the prevalence of protease inhibitor (PI) resistance among Kenyan IDUs remains undetermined. We, therefore, explored PI resistance mutations and their association with viral load and CD4+ T cell counts in HIV-1 infected IDUs (ART-naive, n = 32; and -experienced, n = 47) and non-drug users (ART-naive, n = 21; and -experienced, n = 32) naive for PI treatment from coastal Kenya.

Results: Only IDUs harboured major PI resistance mutations consisting of L90M, M46I and D30 N among 3 (6.4 %) ART-experienced and 1 (3.1 %) -naive individuals. Minor PI mutations including A71T, G48E, G48R, I13V, K20I, K20R, L10I, L10V, L33F, L63P, T74S, V11I, and V32L were detected among the ART-experienced (36.2 vs. 46.9 %) and -naive (43.8 vs. 66.7 %) IDUs and non-drug users, respectively. All the four IDUs possessing major mutations had high viral load while three presented with CD4+ T cell counts of <500 cells/ml. Among the ART-naive non-drug users, CD4+ T cell counts were significantly lower in carriers of minor mutations compared to non-carriers (P < 0.05).

Conclusion: Transmitted drug resistance may occur in IDUs underscoring the need for genotyping resistance before initiating PI treatment.

Keywords: Antiretroviral; Coastal Kenya; Drug resistance; HIV-1; Injection drug users; Non-drug users; Protease inhibitor; Treatment-experienced; Treatment-naive.

PubMed Disclaimer

References

    1. UNODC (2014) World drug report 2014
    1. Reid SR. Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J. 2009;6:24. doi: 10.1186/1477-7517-6-24. - DOI - PMC - PubMed
    1. NASCOP. MOH . MARPs surveillance report 2012. Nairobi: NASCOP; 2012.
    1. Hacker MA, Leite I, Friedman SR, Carrijo RG, Bastos FI. Poverty, bridging between injecting drug users and the general population, and “interiorization” may explain the spread of HIV in southern Brazil. Health Place. 2009;15:514–519. doi: 10.1016/j.healthplace.2008.09.011. - DOI - PubMed
    1. Masur H, Michelis MA, Wormser GP, Lewin S, Gold J, Tapper ML, Giron J, Lerner CW, Armstrong D, Setia U, et al. Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med. 1982;97:533–539. doi: 10.7326/0003-4819-97-4-533. - DOI - PubMed